Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-10

FDA Approved: LEVETIRACETAM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for levetiracetam from Mylan Pharmaceuticals Inc., resulting in approval of a generic product. This action formalizes re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)